"A consignment of medical assistance for Nepal to fight against COVID-19 pandemic will arrive in Kathmandu on Tuesday via a special flight. It will also include 2 lakhs capsules of hydroxychloroquine apart from other medical essentials," sources told .
Hydroxychloroquine, an anti-malarial drug has been identified by the US Food and Drug Administration as a possible treatment for the COVID-19 and is being tested on more than 1,500 coronavirus patients in New York.
India, which produces the anti-malarial drug in bulk, has promised to provide it to more than 55 nations around the globe.
"Nepal will be receiving it on a grant basis. We have kept our neighbours in priority," senior official working with the mission added.
India has said it will send the anti-malaria drug to Afghstan, Bhutan, Bangladesh, Maldives, Sri Lanka, and Myanmar as well. The drug which is being used in COVID-19 therapy has already reached the United States, Mauritius and Seychelles.
Nepal till date has reported 31 positive cases of COVID-19 out of which 30 are imported and one of local transmission. Out of the total 31 cases, the tally of active cases stands at 28, with 3 recoveries.
( With inputs from ANI )